YUMAB is a world leading provider of contract research, technologies, and R&D services dedicated to the development of fully human therapeutic antibodies. As a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO), YUMAB offers its clients optimised antibody development solutions, facilitating the discovery and development of novel fully human antibodies for various therapeutic applications.

Services include:
– Discovery and development of fully human antibodies
– Antibody engineering and optimisation
– Cell line development
– Process development and manufacturing
– Analytical development and quality control
– Preclinical development support

YUMAB is committed to delivering high-quality services tailored to meet the specific needs of the pharmaceutical industry. For more information, please visit yumab.com.